C07C 237/48
Carboxylic acid amides, the carbon skeleton of the acid part being further
Official title: having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system of the same carbon skeleton
C07C237/48 (Carboxylic acid amides, the carbon skeleton of the acid part being further) appears on 98 US grants and 105 published applications in this corpus.
Search patents in C07C- Granted patents
- 98
- Published applications
- 105
- Assignees
- 70
- Inventors
- 340
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 8 | 0 |
| 2000 | 0 | 0 |
| 2001 | 3 | 1 |
| 2002 | 3 | 5 |
| 2003 | 3 | 0 |
| 2004 | 1 | 6 |
| 2005 | 4 | 5 |
| 2006 | 2 | 1 |
| 2007 | 3 | 1 |
| 2008 | 1 | 2 |
| 2009 | 0 | 7 |
| 2010 | 2 | 4 |
| 2011 | 0 | 1 |
| 2012 | 8 | 9 |
| 2013 | 7 | 6 |
| 2014 | 8 | 10 |
| 2015 | 7 | 2 |
| 2016 | 3 | 2 |
| 2017 | 1 | 4 |
| 2018 | 6 | 6 |
| 2019 | 4 | 3 |
| 2020 | 3 | 7 |
| 2021 | 6 | 8 |
| 2022 | 4 | 2 |
| 2023 | 1 | 6 |
| 2024 | 1 | 1 |
| 2025 | 0 | 4 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Arylamides and methods of use thereof26 May 2026US 12,637,414 B2Genzyme Corporation
- 3,5-diaminobenzoic acid compound, and Pin1 inhibitor and therapeutic agent for inflammatory diseases using same10 Feb 2026US 12,545,643 B2Amenis Bioscience, Inc.
- Bicyclic compounds9 Jan 2024US 11,866,431 B2Vivace Therapeutics, Inc.
- Amide derivatives, process for preparation thereof and use thereof as insecticide19 Sep 2023US 11,760,742 B2Mitsui Chemicals, Inc.
- PPAR agonists23 Aug 2022US 11,420,934 B2Mitobridge, Inc.
- Tetraline, phenylcyclobutane and phenylcyclopentane analogs as rxfp1 agonists10 Sep 2026US 2026/0265208 A1Bristol-Myers Squibb Company
- Substituted tetracycline compounds for treatment of inflammatory skin disorders15 Jan 2026US 2026/0015317 A1Paratek Pharmaceuticals, Inc.
- Inhibitors of antimocrobial resistance and methos using same23 Oct 2025US 2025/0325542 A1Baylor College of Medicine
- Novel benzene derivative and immunosuppression-related use thereof25 Sep 2025US 2025/0296909 A1Provibio Co., Ltd.
- Pcna inhibitors and uses thereof29 May 2025US 2025/0171404 A1City of Hope
Most cited
By later US patents
- Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives68US 5,877,218 ATeva Pharmaceutical Industries Ltd. · 1999
- Gastin and CCK receptor ligands50US 5,795,907 AJames Black Foundation Limited · 1998
- Gastrin and CCK antagonists49US 5,912,260 AJames Black Foundation Limited · 1999
- Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds47US 8,450,344 B2Aerie Pharmaceuticals, Inc. · 2013
- 1-ether and 1-thioether-naphthalene-2-carboxamides as inhibitors of cell adhesion and as inhibitors of the activation of HIV40US 5,434,188 AWarner-Lambert Company · 1995